Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia restricts use of cough and cold medicines in children; new labelling required from 1 Sept

This article was originally published in SRA

Executive Summary

Drug sponsors marketing cough and cold medicines in Australia will have to start amending their labelling and packaging from 1 September onwards to state that such products should not be given to children below six years of age1. Labels will also have to reflect that for children aged six to 11 years, these medicines should only be allowed on the advice of a doctor, pharmacist or nurse practitioner.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel